πŸ‡ΊπŸ‡Έ FDA
Patent

US 12365873

Methods for transducing immune cells

granted A61KA61K40/11A61K40/31

Quick answer

US patent 12365873 (Methods for transducing immune cells) held by Allogene Therapeutics, Inc. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Allogene Therapeutics, Inc.
Grant date
Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/40, A61P